𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer

✍ Scribed by Georgios V. Koukourakis; Anastasia Sotiropoulou-Lontou

Publisher
Springer Milan
Year
2011
Tongue
Spanish
Weight
80 KB
Volume
13
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Targeted Therapies for Metastatic Esopha
Targeted Therapies for Metastatic Esophagogastric Cancer
✍ Deepa Reddy; Zev A. Wainberg πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 202 KB

## Opinion statement The prognosis and long-term survival for patients with metastatic esophagogastric cancer (EGC) is poor. Historically, the mainstay of treatment has been combination chemotherapy. More recently, a number of targeted therapies have been developed and are being studied with the go

Systemic therapy for metastatic colorect
Systemic therapy for metastatic colorectal cancer : Current questions
✍ Dan S. Zuckerman; Jeffrey W. Clark πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

## Abstract A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase long‐term survival in patients with liver and/or lung metastases also has been firmly established. It has become inc